COVID-19 Among People Living with HIV: A Systematic Review

Mirzaei, Hossein; McFarland, Willi; Karamouzian, Mohammad; Sharifi, Hamid

doi:10.1007/s10461-020-02983-2

Cited by 187 publications

(182 citation statements)

References 46 publications

Supporting

Mentioning

158

Contrasting

Unclassified

Order By: Relevance

“…This work builds on previous reviews on specific sexual health issues and COVID-19, which generally focused on the intersection of HIV and COVID-19 and did not examine sexual health more broadly. [6][7][8] We found that MSM may be moving back toward pre-pandemic levels of sexual activity. Abstinence-based strategies to limit HIV transmission are generally ineffective 133 and it is not reasonable to expect people to refrain from sexual activity amid a pandemic.…”

Section: Discussionmentioning

confidence: 82%

“…While several reviews have sought to synthesise existing and fast-changing evidence on COVID-19 and health outcomes, little attention has been paid to the pandemic's effects on sexual health and wellbeing. There have been, however, several reviews focused on HIV specifically, [6][7][8] but not on sexual health more broadly. Sexual health is a central feature in overall health and well-being, and in the socioeconomic development of communities and countries 9 ; understanding if and how the COVID- 19 11 Reporting of results conformed to Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Sexual health (excluding reproductive health, intimate partner violence and gender-based violence) and COVID-19: a scoping review

et al. 2021

View full text Add to dashboard Cite

ObjectivesThe COVID-19 pandemic has exposed and exacerbated existing socioeconomic and health disparities, including disparities in sexual health and well-being. While there have been several reviews published on COVID-19 and population health disparities generally—including some with attention to HIV—none has focused on sexual health (ie, STI care, female sexual health, sexual behaviour). We have conducted a scoping review focused on sexual health (excluding reproductive health (RH), intimate partner violence (IPV) and gender-based violence (GBV)) in the COVID-19 era, examining sexual behaviours and sexual health outcomes.MethodsA scoping review, compiling both peer-reviewed and grey literature, focused on sexual health (excluding RH, IPV and GBV) and COVID-19 was conducted on 15 September 2020. Multiple bibliographical databases were searched. Study selection conformed to Joanna Briggs Institute (JBI) Reviewers’ Manual 2015 Methodology for JBI Scoping Reviews. We only included English-language original studies.ResultsWe found that men who have sex with men may be moving back toward pre-pandemic levels of sexual activity, and that STI and HIV testing rates seem to have decreased. There was minimal focus on outcomes such as the economic impact on sexual health (excluding RH, IPV and GBV) and STI care, especially STI care of marginalised populations. In terms of population groups, there was limited focus on sex workers or on women, especially women’s sexual behaviour and mental health. We noticed limited use of qualitative techniques. Very few studies were in low/middle-income countries (LMICs).ConclusionsSexual health research is critical during a global infectious disease pandemic and our review of studies suggested notable research gaps. Researchers can focus efforts on LMICs and under-researched topics within sexual health and explore the use of qualitative techniques and interventions where appropriate.

show abstract

Section: Discussionmentioning

confidence: 82%

Section: Introductionmentioning

confidence: 99%

Sexual health (excluding reproductive health, intimate partner violence and gender-based violence) and COVID-19: a scoping review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Positive outcomes have been reported in case series from Italy [ 34 ], Spain [ 35 ], Germany [ 36 ] and the US [ 37 ]. However, a recent systematic review reported high proportion of death among COVID-19 and HIV co-infected patients [ 38 ] and HIV doubled the risk of COVID-19 mortality in South Africa [ 39 ]. Nigeria has one of the largest numbers of people living with HIV in SSA and there is greater concern for those with low CD4 cell count, advanced disease, high viral load, and those not on antiretroviral treatment (ART) given that COVID-19 also has adverse immunological and clinical effects [ 36 , 38 ].…”

Section: Discussionmentioning

confidence: 99%

Outcomes of COVID-19 patients with comorbidities in southwest Nigeria

et al. 2021

View full text Add to dashboard Cite

Background Data on the comorbidities that result in negative outcomes for people with COVID-19 are currently scarce for African populations. This study identifies comorbidities that predict death among a large sample of COVID-19 patients from Nigeria. Methods This was a retrospective analysis of medical records for 2184 laboratory confirmed cases of COVID-19 in Lagos, southwest Nigeria. Extracted data included age, sex, severity of condition at presentation and self-reported comorbidities. The outcomes of interest were death or discharge from facility. Results Most of the cases were male (65.8%) and the median age was 43 years (IQR: 33–55). Four hundred and ninety-two patients (22.5%) had at least one comorbidity and the most common amongst them were hypertension (74.2%) and diabetes (30.3%). The mortality rate was 3.3% and a significantly higher proportion of patients with comorbidities died compared to those with none. The comorbidities that predicted death were hypertension (OR: 2.21, 95%CI: 1.22–4.01), diabetes (OR: 3.69, 95% CI: 1.99–6.85), renal disease (OR: 12.53, 95%CI: 1.97–79.56), cancer (OR: 14.12, 95% CI: 2.03–98.19) and HIV (OR: 1.77–84.15]. Conclusion Comorbidities are prevalent and the associated risk of death is high among COVID-19 patients in Lagos, Nigeria. Public enlightenment, early identification and targeted care for COVID-19 cases with comorbidities are recommended as the pandemic evolves.

show abstract

“…Forewarning to take extra deterrents against COVID-19 has been emphasized for persons with comorbidities such as asthma, diabetes, severe cardiovascular conditions, obesity, chronic diseases, and immune-compromised persons, including PLWH [7][8][9][10]. In addition, PLWH have higher rates of certain underlying health conditions [11].…”

Section: Introductionmentioning

confidence: 99%

Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda

et al. 2020

View full text Add to dashboard Cite

As with other countries globally, Rwanda has faced a recent outbreak of the coronavirus disease 2019 (COVID-19) against a backdrop of an HIV epidemic. At present, there is no successful cure or vaccine for both COVID-19 and HIV. People with underlying conditions, including HIV, are at increased risk of severe COVID-19 manifestations. This underscores the need to enhance the knowledge, attitudes, and practice of people living with HIV (PLWH) to protect this population against COVID-19. An institution-based cross-sectional study was conducted from August 31 to September 18, 2020 among 376 participants who were selected by a simple random sampling technique. A pretested and structured self-administered questionnaire was used to collect data. Quality scores were calculated as a measure of the participants' knowledge, attitudes, and practice (KAP) levels. The student t-test was used to compare continuous variables between low (<65%) and high (≥65%) KAP scores. The chi-square test was used to determine the association between KAP scores and categorical variables. All decisions on statistical tests were concluded at 5% level of significance. All statistical analysis was performed using STATA statistical package version 11.2 (STATA Corp., Texas, USA). Of the 376 participants, 363 (97%) obtained a high knowledge score, while more than a quarter of the participants (26%) had a poor attitude score, and the majority (90%) having a high practice score. There was no association between gender, age, place of residence, employment, or duration on ART and knowledge score. Employment status and duration on antiretroviral treatment (ART) were significantly associated with attitude scores (p = 0.004 and p = 0.013, respectively). Gender and duration on ART were significantly associated with practice scores (p = 0.02 and p = 0.012, respectively). There was a moderate positive correlation (r = 0.57) between knowledge and attitude scores, and knowledge and practice scores (r = 0.55). There was a strong positive correlation (r = 0.67) between attitude scores and practice scores. Health education programs tailored for PLWH and aimed at mobilizing and improving COVID-19-related knowledge, attitude, and practice should be prioritized in the Rwandan COVID-19 response.

show abstract

COVID-19 Among People Living with HIV: A Systematic Review

Cited by 187 publications

References 46 publications

Sexual health (excluding reproductive health, intimate partner violence and gender-based violence) and COVID-19: a scoping review

Sexual health (excluding reproductive health, intimate partner violence and gender-based violence) and COVID-19: a scoping review

Outcomes of COVID-19 patients with comorbidities in southwest Nigeria

Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda

Contact Info

Product

Resources

About